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Summary
 
As guardian of the genome the tumor suppressor p53
controls a crucial point in protection from cellular damage
and response to stressors. Activation of p53 can have
beneficial (DNA repair) or detrimental (apoptosis) con-
sequences for individual cells. In either case activation
of 
 
p53
 
 is thought to safeguard the organism at large from
the deleterious effects of various stresses. Recent data
suggest that the function of p53 might also play a role
in the regulation of organismal lifespan. Increased p53
activity leads to lifespan shortening in mice, while apparent
reduction of p53 activity in flies leads to lifespan extension.
Although the mechanism by which p53 regulates lifespan
remains to be determined, these findings highlight the possi-
bility that careful manipulation of p53 activity during adult
life may result in beneficial effects on healthy lifespan.
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It has long been known that mice that are deficient for p53
are prone to develop tumors and die prematurely (Donehower
 
et al
 
., 1992). Even one functional copy of the p53 gene can
protect mice dramatically from these cancers, albeit not quite
as effectively as two functional copies. Therefore, more p53
activity appeared to be more protective against cancers.
In 2002, Donehower and colleagues serendipitously studied
the effects of increased p53 activity, when, due to a targeting
event gone wrong, they created a mouse that expressed a
truncated version of p53 (Tyner 
 
et al
 
., 2002). This truncated
version, p24, is thought to bind to regular length wild-type p53.
This unique complex is hypothesized to possess increased
constitutive activity (Vijg & Hasty, 2005). As predicted, increased
p53 activity was very effective against tumor formation. In the
mouse line with the strongest allele only two mice, or 6%,
developed cancers. In contrast, 48% of wild-type animals and
over 80% of mice with only one functional copy of the tumor
suppressor developed cancers. These results were confirmed
2 years later with the generation of a mouse by Scrable and
colleagues that over expresses a naturally occurring truncated
version of p53 (Maier 
 
et al
 
., 2004). This p44 molecule functions
in a similar way to the artificial short p24 isoform and binds full
length p53 to bestow heightened activity to endogenous p53
by forming a heteromeric complex. As with the earlier hyper-
active p53 model, these mice are exceptionally resistant to
cancer. The hypothesis was further put to the test by Serrano
and colleagues who engineered a mouse with an additional
copy of the whole p53 genomic region. Once again, these mice
were remarkably tumor resistant (Garcia-Cao 
 
et al
 
., 2002).
Similar results were obtained by Perry and colleagues when
the activity of the p53 inhibitor Mdm2 was decreased, which
boosted inducible p53 activity (Mendrysa 
 
et al
 
., 2006).
In humans, lifespan gains over the last century have in part
been achieved due to better treatment of cancers. Do therefore
mice also benefit from improved tumor suppression? Mice, in
which only the magnitude of the inducible p53 response had
been increased (through extra p53 gene dosage or reduction
of Mdm2 activity), surprisingly did not live longer than controls.
Even more astonishing, instead of living longer, the mice with
constitutively hyperactive p53 (through incorporation of a short-
ened form of p53 into the p53 tetramer), actually died earlier
than their wild-type counterparts.
Why does increased tumor protection not translate into
longer lifespans for these animals? Several markers of aging,
including muscle loss, osteoporosis, skin atrophy and defects in
wound healing, were found to be greatly accelerated in mice
with hyperactive p53. No markers of accelerated aging were
found in the other two models, leading to the speculation that,
rather than increased p53 activity per se, altered functionality
of the p44(p24)/p53 complex might explain those premature aging
phenotypes (Mendrysa 
 
et al
 
., 2006). That p53 might play a role
in lifespan regulation is further suggested by other mouse models
with premature aging phenotypes (Vogel 
 
et al
 
., 1999; Cao 
 
et al
 
.,
2003). Taken together, these observations indicate that modifica-
tion of p53 function affects longevity and clearly establish a link
between p53, cancer formation and lifespan regulation.
If p53 indeed controls the crossroad between cancer and
aging, then tampering with p53 activity could either yield longer
lifespan, albeit at the cost of increased cancer risk, when its
activity is diminished, or low tumor risk, at the cost of a short-
ened lifespan, if its activity is increased (Campisi, 2002; Done-
hower, 2005). Neither of these options are particularly attractive
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for practical applications. However, postmitotic cells are largely
resistant to tumor formation, which might help avoid those
detrimental trade-offs. If tumor formation could be avoided,
reduction of p53 activity might then be able to extend healthy
lifespan. Thus, we decided to test the hypothesis that reduced
p53 activity might lead to beneficial effect on lifespan in an
organism that consists of mostly postmitotic tissues, the fruit
fly 
 
Drosophila melanogaster
 
. The fly genome contains a fairly
well conserved p53 homolog, Dmp53, that has been shown to
regulate apoptosis in the developing fly embryo (Nordstrom &
Abrams, 2000). Not surprisingly, the lifespan of p53 null flies
is shortened compared with their wild-type controls (Bauer
 
et al
 
., 2005). This most likely reflects a positive role of p53
during embryonic development (Jassim 
 
et al
 
., 2003). However,
when p53 activity is reduced specifically in neurons through the
expression of dominant negative versions of Dmp53, lifespan
extension of up to 58% is seen without a loss in fecundity or
physical activity. Furthermore, when expression of the dominant
negative versions of Dmp53 is restricted to only adult neurons,
flies also live longer than controls (up to 26% longer). Expres-
sion of these same dominant negative constructs in other adult
fly tissues including muscle and fat body yields no lifespan
extension, and perhaps even a lifespan shortening. These obser-
vations give strong support to the hypothesis that a reduction
of p53 activity can have beneficial effects on lifespan if tumor
formation can be avoided and furthermore highlight the
importance of the nervous system in longevity determination.
These findings could then be transferred to mammalian systems,
as even mammalian neurons are much more tumor resistant
than other dividing tissues.
How does reduction of p53 activity extend lifespan? One
clue comes from the observation that calorie-restricted long-
lived flies do not show additional lifespan extension when
DN-Dmp53 is also expressed, indicating that Dmp53 and calorie
restriction are related (Bauer 
 
et al
 
., 2005). Exposing flies to
calorie restriction (CR) has been shown to increase levels of
the histone deacetylase dSir2 (Rogina 
 
et al
 
., 2002) and neuronal
overexpression of dSir2 extends 
 
Drosophila
 
 lifespan (Rogina &
Helfand, 2004). In addition, CR-dependent lifespan extension
is blocked in flies lacking dSir2. Interestingly, it is known in
mammalian systems that the dSir2 ortholog SIRT1 can deacetylate
and inactivate p53 (Smith, 2002). Taken together, these results
suggest that CR may in part be mediated by sirtuins and their
downstream target p53.
In contrast, modulation of the insulin-signaling pathway through
overexpression of dFOXO only leads to extended lifespans when
dFOXO is overexpressed in the fat body, but not when over-
expressed in neurons (Giannakou 
 
et al
 
., 2004; Hwangbo 
 
et al
 
.,
2004). As noted above, this is the opposite of what is seen with
expression of dominant negative Dmp53 constructs; neuronal,
but not fat body expression is important for lifespan extension.
On the surface, these data suggest that the insulin-signaling
pathway and the CR/Sir2 pathway are two separate mechan-
isms for lifespan modulation in the fly. Tissue-specific signaling
pathways might exist that respond to different cues and control
lifespan by different mechanisms. However, it may be that these
two disparate pathways are more related than initially expected.
Similar to p53, the activity of FOXO is modified by SIRT1 (Brunet
 
et al
 
., 2004; Daitoku 
 
et al
 
., 2004), and in mammals CR is known
to change insulin levels (Wanagat 
 
et al
 
., 1999). Furthermore,
p53 has been linked directly to insulin-signaling (Hursting 
 
et al
 
.,
2001, 2004; Maier 
 
et al
 
., 2004). Thus, there may be points of
interaction or cross-talk between these two pathways, either at
an intra- or at an intercellular level. Thus, these two different
pathways may turn out to be part of the same pathway. In this
scenario, stimulating a particular pathway in one tissue (nervous
system or fat body) could result in a signal that is transmitted
to the other tissue, inducing systemic changes leading to a pro-
longation of lifespan. Future experiments will certainly untangle
these difficult questions.
Regardless of whether p53 is part of the CR or the insulin pathway,
or both, its downstream effectors in the fly remain unknown.
In developing embryos, Dmp53 has been shown to control
apoptosis, but not cell cycle arrest (Brodsky 
 
et al
 
., 2000; Jin
 
et al
 
., 2000; Ollmann 
 
et al
 
., 2000), and loss of Dmp53 leads to
dysregulation of DNA repair pathways (Sogame 
 
et al
 
., 2003). It
is conceivable that down-regulation of Dmp53 leads to a dimin-
ished response to stimuli that would otherwise lead to apoptotic
cell death. In the brain, this might account for slow cell loss of
neurons that cannot be replaced (Campisi, 2002), thus leading
to aging. Induction of apoptosis by Dmp53 has been shown in
embryos to be regulated at the transcriptional level through
up-regulation of the pro-apoptotic molecule reaper (Brodsky
 
et al
 
., 2000). However, this functionality appears to be changed
during larval and pupal development, as well as in the adult, as
reaper-related Dmp53-responsive transcriptional reporters lose
their ability to respond to Dmp53-activating stimuli (Bauer &
Helfand, unpublished data). The only well-described function-
ality of Dmp53 in the fly is the induction of caspase-dependent
apoptosis, yet two different studies found no evidence to support
a role for neuronal, caspase-dependent apoptosis in longevity
determination (Bauer 
 
et al
 
., 2005; Zheng 
 
et al
 
., 2005).
If Dmp53 does not regulate caspase-dependent apoptosis in
the adult fly brain, what other mechanisms could account for
the lifespan extension seen by overexpression of DN-Dmp53?
One possibility is other forms of neuronal cell death that may
normally play a role in the aging process.
Apoptosis has been demonstrated to proceed by caspase-
independent pathways through apoptosis-inducing factor (AIF),
but no 
 
Drosophila
 
 homolog of AIF has been described thus far.
Autophagy has been shown to be a major contributing factor
to neuronal cell death (Yuan 
 
et al
 
., 2003). While most autophagy
in neurons is tightly controlled and appears to be protective
against neurodegenerative disorders, dysregulation of autophagy
might also result in cell loss. The role of autophagy in aging,
however, is poorly understood and remains to be elucidated.
Another form of cell death that, like autophagy, is characterized
by cytoplasmic vacuoles, has been called paraptosis. Paraptosis
may be induced by the insulin-like growth factor receptor and
is mediated by mitogen activated protein (MAP) kinases (Broker 
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et al
 
., 2005). This might link paraptosis to p53, as mice with
hyperactive p53 also show hyperactivation of the insulin-like
growth factor (IGF) pathway (Maier 
 
et al
 
., 2004). The role of
paraptosis in aging or neurodegenerative disease has not been
determined yet.
Recently, a form of programmed cell death has been
described that shares features of both apoptosis and necrosis
and has subsequently been termed necroptosis (Degterev
 
et al
 
., 2005). Interestingly, necrostatin-1, a compound that
blocks necroptosis, was found to be protective against cell
death induced by ischemic brain injury in mice. This indicates
that some neuronal cell loss occurs by a necroptotic mechanism
and suggests a novel pathway that reduction of Dmp53
activity could exploit to protect the brain from cell loss of
essential cells. It remains to be seen if necroptotic cell loss occurs
in the aging fly brain and if necrostatin-1 can protect against it.
An alternative to losing important functionality in the brain
by permanent cell loss would be to functionally disable or
alter cells without actually killing them. In fibroblasts, replicative
senescence constitutes such a pathway (Campisi, 2005).
Importantly, replicative senescence is indeed controlled by
p53. Certainly, replicative senescence cannot occur in postmitotic
cells such as neurons. However, similarly p53-controlled events
could take place that irrevocably change or shut down neuronal
function, while keeping the cells themselves alive. Markers for
such a disabled state have yet to be developed. Loss of func-
tional neurons, either through a cell death or a senescence-like
mechanism, could conceivably contribute to aging phenotypes
and be counteracted by reduction of p53 function.
Finally, p53 has been demonstrated to activate apoptosis in
a transcription-independent manner through interaction with
the pro-apoptotic Bcl-2 family member Bax (Chipuk 
 
et al
 
.,
2004). In addition, p53 has also been shown to directly trans-
locate to the mitochondria where it binds Bcl-2 family members
Bak, Bcl-2 and Bcl-XL (Mihara 
 
et al
 
., 2003; Leu 
 
et al
 
., 2004).
Inside the mitochondria, p53 can bind to manganese-superoxide
dismutase, inhibiting its scavenger activity (Zhao 
 
et al
 
., 2005).
In either scenario, a breakdown of mitochondrial membrane
potential is the consequence, followed by the release of pro-
apoptotic factors and loss of mitochondrial functionality. Either
catastrophic breakdown of mitochondrial function or simply a
contribution by p53 to chronic mitochondrial dysfunction might
be a factor underlying the aging process (Wallace, 2005), which
could be offset by p53 reduction.
In light of the fact that Dmp53 transcriptional profile changes
during fly development, it might also be possible that Dmp53
function changes, exchanging function as a transcriptional re-
gulator to that of a signaling pathway modulator through direct
interaction. It is conceivable that p53 influences biological
events other than apoptosis through these direct protein–
protein interactions, which might be a major mechanism in the
adult fly. Interestingly, two-hybrid analysis has revealed protein
interaction partners of Dmp53 that are involved in a variety of
processes, including DNA repair and metabolism (Giot 
 
et al
 
.,
2003; Stanyon 
 
et al
 
., 2004). The role of these interactions in
longevity determination has still to be elucidated. One thing,
however, is for certain: when scientists thought they had a
handle on p53, it has always surprised by revealing a new,
unexpected function. The p53 story is far from over.
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